Abstract: The present invention is a battery-powered, Bluetooth-enabled wireless earpiece with a microphone mounted for use inside the wearer's ear canal. Its intended purpose is to transmit sounds such as snoring, generated in the user's upper airway, to a separate device for recording and/or sound analysis. In particular, the present invention is composed of a small housing that fits to all or part of the user's external ear, with a microphone that fits inside the external ear canal. An earplug sandwiched between the microphone and the housing insulates the microphone from noises generated in the outside environment. The housing of the present invention contains on the inside a rechargeable battery and Bluetooth chip, as well as necessary wiring. On its surface, the housing has an ear support piece, an on/off switch, an indicator LED, and an adaptor jack for connection to a battery charger or power cord.

Abstract: Methods, systems and computer program products that notify technicians of work to be performed on a telecommunications system are provided. Interconnections with patch panel connector ports are monitored and a work order is generated in response to detecting the relocation of a patch cord connector at a patch panel. A technician automatically is notified that a work order has been generated. The technician is requested to acknowledge receipt of a work order notification. If an acknowledgement is not received within a predetermined period of time, an alternate technician is notified of the work order. A list of work orders are displayed on a display in communication with the telecommunications system. Displayed work orders can be filtered such that the a technician only views work orders he/she is authorized to view. A technician can select a displayed work order and retrieve additional information from a server managing the work orders.

Abstract: Methods, systems and computer program products for interconnecting network equipment with a telecommunications system includes identifying a patch panel connector port to be connected to a network equipment port, generating a work order for connecting the identified patch panel connector port to the network equipment port via a patch cord, monitoring the identified patch panel connector port to detect whether a patch cord connector has been inserted therein within a predetermined period of time, and monitoring the network equipment port for communications activity within a predetermined period of time. If a patch cord connector has not been inserted within the identified patch panel connector port within the predetermined period of time and/or if communications activity has not been detected at the network equipment port within the predetermined period of time, a technician is notified. Network equipment ports and patch panel ports are monitored for authorized and unauthorized connections.

Abstract: A telecommunications patching system includes a patch panel having a plurality of connector ports, and having an RFID reader and RF antennas associated with the connector ports. A plurality of patch cords are configured to selectively interconnect pairs of the connector ports. Each patch cord has opposite ends and a respective connector secured to each end that is configured to be removably secured within a connector port. Each connector of a respective patch cord includes an RFID tag. The RFID tags for a respective patch cord have the same unique identifier stored therewithin. The RF antenna associated with a connector port emits RF signals that cause a patch cord connector RFID tag to transmit its identifier. Each RF antenna detects the transmitted identifier of a patch cord connector RFID tag when the respective patch cord connector is inserted within, and removed from, a respective one of the connector ports.

Abstract: Intestinal epithelial cells of a mammalian subject are genetically altered to operatively incorporate a gene which expresses a protein which has a desired therapeutic effect. Intestinal cell transformation is accomplished by administration of a formulation containing DNA and is preferably administered orally. Oral or other intragastrointestinal routes of administration provide a simple method of administration. The expressed protein is secreted directly into the gastrointestinal tract and/or bloodstream to obtain therapeutic blood levels of the protein, thereby treating the patient in need of the protein. The delivery system of the invention provides short or long term delivery of therapeutic gene products.

Abstract: The present invention provides methods of delivering a secreted protein into the bloodstream of a mammal. A nucleic acid molecule encoding the protein is introduced into the gastrointestinal tract of the mammal, and the nucleic acid molecule enters an intestinal epithelial cell, where the protein is produced and secreted into the bloodstream of the mammal.

Abstract: A liquid toner or toner concentrate comprising: pigmented toner particles in an amount of 0.5% to 20% by weight; a carrier liquid comprising: a liquid hydrocarbon; a silicone based additive; and a charge director, wherein the silicone based additive comprises a release life enhancer additive chosen from the group consisting of: a liquid silicone material having a viscosity of at least 5,000 centistokes; a silicone gum; a silicone surfactant; and a non-reactive silicone fluid.

Abstract: Secretory gland cells, particularly pancreatic and salivary gland cells, are genetically altered to operatively incorporate a gene which expresses a protein which has a desired therapeutic effect on a mammalian subject. The expressed protein is secreted directly into the gastrointestinal tract and/or blood stream to obtain therapeutic blood levels of the protein thereby treating the patient in need of the protein. The transformed secretory gland cells provide long term therapeutic cures for diseases associated with a deficiency in a particular protein or which are amenable to treatment by overexpression of a protein.

Abstract: Secretory gland cells, particularly pancreatic and salivary gland cells, are genetically altered to operatively incorporate a gene which expresses a protein which has a desired therapeutic effect on a mammalian subject. The expressed protein is secreted directly into the gastrointestinal tract and/or blood stream to obtain therapeutic blood levels of the protein thereby treating the patient in need of the protein. The transformed secretory gland cells provide long term therapeutic cures for diseases associated with a deficiency in a particular protein or which are amenable to treatment by overexpression of a protein.

Abstract: The present invention provides methods of delivering a secreted protein into the bloodstream of a mammal. A nucleic acid molecule encoding the protein is introduced into the gastrointestinal tract of the mammal, and the nucleic acid molecule enters an intestinal epithelial cell, where the protein is produced and secreted into the bloodstream of the mammal.

Abstract: Secretory gland cells, particularly pancreatic and salivary gland cells, are genetically altered to operatively incorporate a gene which expresses a protein which has a desired therapeutic effect on a mammalian subject. The expressed protein is secreted directly into the gastrointestinal tract and/or blood stream to obtain therapeutic blood levels of the protein thereby treating the patient in need of the protein. The transformed secretory gland cells provide long term therapeutic cures for diseases associated with a deficiency in a particular protein or which are amenable to treatment by overexpression of a protein.

Abstract: Intestinal epithelial cells of a mammalian subject are genetically altered to operatively incorporate a gene which expresses a protein which has a desired effect. The method of the invention comprises administration of a formulation containing DNA to the gastrointestinal tract, preferably by an oral route. The expressed recombinant protein is secreted directly into the bloodstream. Of particular interest is the use of the method of the invention to provide for short term delivery of gene products to the bloodstream.

Abstract: Secretory gland cells, particularly pancreatic and salivary gland cells, are genetically altered to operatively incorporate a gene which expresses a protein which has a desired therapeutic effect on a mammalian subject. The expressed protein is secreted directly into the gastrointestinal tract and/or blood stream to obtain therapeutic blood levels of the protein thereby treating the patient in need of the protein. The transformed secretory gland cells provide long term therapeutic cures for diseases associated with a deficiency in a particular protein or which are amenable to treatment by overexpression of a protein.

Abstract: Intestinal epithelial cells of a mammalian subject are genetically altered to operatively incorporate a gene which expresses a protein which has a desired therapeutic effect. Intestinal cell transformation is accomplished by administration of a formulation composed primarily of naked DNA, and is preferably administered orally. Oral or other intragastrointestinal routes of administration provide a simple method of administration, while the use of naked nucleic acid avoids the complications associated with use of viral vectors to accomplish gene therapy. The expressed protein is secreted directly into the gastrointestinal tract and/or blood stream to obtain therapeutic blood levels of the protein thereby treating the patient in need of the protein. The transformed intestinal epithelial cells provide short or long term therapeutic cures for diseases associated with a deficiency in a particular protein or which are amenable to treatment by overexpression of a protein.

Abstract: Secretory gland cells, particularly pancreatic and salivary gland cells, are genetically altered to operatively incorporate a gene which expresses a protein which has a desired therapeutic effect on a mammalian subject. The expressed protein is secreted directly into the gastrointestinal tract and/or blood stream to obtain therapeutic blood levels of the protein thereby treating the patient in need of the protein. The transformed secretory gland cells provide long term therapeutic cures for diseases associated with a deficiency in a particular protein or which are amenable to treatment by overexpression of a protein.

Abstract: Secretory gland cells, particularly pancreatic and salivary gland cells, are genetically altered to operatively incorporate a gene which expresses a protein which has a desired therapeutic effect on a mammalian subject. The expressed protein is secreted directly into the gastrointestinal tract and/or blood stream to obtain therapeutic blood levels of the protein thereby treating the patient in need of the protein. The transformed secretory gland cells provide long term therapeutic cures for diseases associated with a deficiency in a particular protein or which are amenable to treatment by overexpression of a protein.